Net Scientific's portfolio company and circulating tumor cell capture specialist Vortex Biosciences adds to its board of directors Deborah Neff, ex-chief operating officer of Complete Genomics and a former BD executive.
Circulating tumor cell capture company Vortex Biosciences Inc. has appointed the ex-chief operating officer of Complete Genomics Inc., Deborah Neff, as non-executive director. Neff joins the company's board of directors ahead of the launch of its first product, the VTX-1 liquid biopsy system.
During her time at Complete Genomics, Neff was responsible for leading the company's operations, commercial and product development. Prior to...
Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.
Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.
Research recently published in JAMA Internal Medicine found that the FDA met its review timeline goals for the majority of breakthrough devices – but also revealed some apparent shortcomings in safety data supporting the submissions.
